Eneura, Inc.

FDA Regulatory Profile

Eneura, Inc. appears in FDA public data with 0 recalls, 3 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on May 16, 2023.

Summary

Total Recalls
0
510(k) Clearances
3
Inspections
1
Compliance Actions
0

Known Names

eneura, eneura®

Recent 510(k) Clearances

K-NumberDeviceDate
K230358SAVI Dual (TM) Migraine TherapyMay 16, 2023
K162797SpringTMSJune 26, 2017
K161663sTMS miniAugust 23, 2016